To compare the efficacy of intraarticular knee injection between leukocyte-rich and leukocyte-poor platelet-rich plasma in knee osteoarthritis treatment
Participants were randomized into 3 groups (leukocyte-rich platelet-rich plasma (LR-PRP), leukocyte-poor platelet-rich plasma (LP-PRP), and Corticosteroid (CS)). The primary outcome of this study is The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and was measured pre-treatment and post-treatment at follow-up at 1, 3, and 6 months
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
93
Intra-articular knee injection
Intra-articular knee injection
Intra-articular knee injection
Queen Savang Vadhana Memorial Hospital
Si Racha, Changwat Chon Buri, Thailand
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
a self-administered questionnaire consisting of 24 items divided into 3 subscales Pain (5 items) Stiffness (2 items) Physical Function (17 items)
Time frame: 6 months
VAS pain
total of 10 score
Time frame: 6 months
the time up and go test
unit: second
Time frame: 6 months
30-second chair stand test
unit second
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.